Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by LiquidRealityon Nov 26, 2018 11:21am
69 Views
Post# 29021377

RE:RE:RE:18 Cents

RE:RE:RE:18 CentsSays Bioteck in THIS subject title that HE wrote “18 cents…Time to buy some more”. Says Bioteck  “100k x.03 = $3000 x 30 = $99k”.” Says Bioteck about an hour later “You have no clue when or how much I'm buying or selling” and “RedRocket, how about you try to keep track of your investment and let me worry about mine?” Yet you continue to tell us every time the stock moves a few pennies up or down. Sigh. And thanks for the share volume update on SEOVF. But that clearly went over your head because there were NO trades on that day as the USA markets were closed on the 22nd. My point was the volume on the Canadian side totally dried up. The Americans will not be buying on the OTC market YET because the bid/ask spread is too big, and there is not enough liquidity. Anyway, enough responding to your drivel.
 
And no matter what I know or do not know, the point to these message boards is to share information, thoughts and insights. I will ask questions even if I think I know the answers because I am interested in what others have to say here, and not just listen to myself talk for my own ego or ulterior motives (as some other posters here seem to have). To be honest my feedback on the good Dr and some others involved in the company is not coming back very strong, but I am hoping that is just because it is no secret that investors here are very fatigued. Very encouraging video from the last post, and I continue to seek information on first patient enrolment and any other pertinent insight anyone has short of insider information. As it seem that Viacyte and SVA has some common ground, I would ask now what’s the beef and why is theirs or SVA’s better? GLTA
 
https://www.evaluate.com/vantage/articles/analysis/spotlight/regenerating-insulin-producing-cells-next-big-thing-diabetes
Bullboard Posts